In the last trading session, 3.34 million Applied Therapeutics Inc (NASDAQ:APLT) shares changed hands as the company’s beta touched 1.87. With the company’s per share price at $0.53 changed hands at -$0.04 or -6.23% during last session, the market valuation stood at $61.67M. APLT’s last price was a discount, traded about -1903.77% off its 52-week high of $10.62. The share price had its 52-week low at $0.54, which suggests the last value was -1.89% down since then.
Analysts gave the Applied Therapeutics Inc (APLT) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.17. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended APLT as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight. Applied Therapeutics Inc’s EPS for the current quarter is expected to be -0.18.
Applied Therapeutics Inc (NASDAQ:APLT) trade information
Instantly APLT was in red as seen at the end of in last trading. With action -10.58%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -38.10%, with the 5-day performance at -10.58% in the red. However, in the 30-day time frame, Applied Therapeutics Inc (NASDAQ:APLT) is -15.66% down.
The consensus price target for the stock as assigned by Wall Street analysts is 4.5, meaning bulls need an upside of 88.22% from its current market value. According to analyst projections, APLT’s forecast low is 4 with 5 as the target high. To hit the forecast high, the stock’s price needs a -843.4% plunge from its current level, while the stock would need to soar -654.72% for it to hit the projected low.
Applied Therapeutics Inc (APLT) estimates and forecasts
Year-over-year growth is forecast to reach -94.47% down from the last financial year.
Consensus estimates given by 3 financial analysts project the company’s revenue in the current quarter to hit an average of 100k. 3 analysts are of the opinion that Applied Therapeutics Inc’s revenue for the current quarter will be 12.32M. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 6,382.46%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -8.72%. The 2025 estimates are for Applied Therapeutics Inc earnings to increase by 1.41%, but the outlook for the next 5-year period is at 41.84% per year.
Applied Therapeutics Inc (NASDAQ:APLT)’s Major holders
VR ADVISER, LLC holds the second largest percentage of outstanding shares, with 66.1112% or 9.54 million shares worth $44.57 million as of 2024-06-30.
Among Mutual Funds, the top two as of Sep 30, 2024 were Vanguard Total Stock Market Index Fund and Simplify Exchange Traded Fds-Simplify Propel Opportunities ETF. With 3.15 shares estimated at $1.67 million under it, the former controlled 2.71% of total outstanding shares. On the other hand, Simplify Exchange Traded Fds-Simplify Propel Opportunities ETF held about 2.42% of the shares, roughly 2.82 shares worth around $1.49 million.
